About the Event

Confirmed Investors:

5AM Ventures, Accelerator Life Science Partners, ACT Medicine, adMare BioInnovations, Amgen Ventures, Amplitude Ventures, AngelMD, Bausch Health, Baxter International, Beijing Konruns Pharmaceutical, Biogen Canada, Biolab Pharma, Bloom Burton & Co, Boast Capital, BOCI Asia, Boehringer Ingelheim, Borealis Ventures, Chinook Therapeutics, CMH Fund, CTI Life Sciences Fund, Detong Capital, Elevate Capital, Emergent BioSolutions, Genesys Capital, Global Health Sciences Venture Fund, Global Strategic Medical, J&J Innovation, Jiangsu Industrial Technology Research Institute, Kensington Capital Partners, KPC Pharmaceuticals, Libang Capital, Lipont Investment, Lumira Ventures, Nimbus Synergies, Novateur Ventures, OKR Financial, Otsuka Pharmaceutical, Quark Venture, Relentless Venture Fund, Rising Tide VC, Sanofi, Servier, Shadow Lake Group, Shandong Huasi Biotechnology, Shandong Jincheng Pharmaceutical Group, Shanghai Bioscience Technology, Shanghai Fosun Pharmaceutical, Shanghai Idental Holdings, Shenzhen Salubris Pharmaceuticals, Sunshine Lake Pharma Co, Social Impact Capital, Taiho Ventures, Takeda Ventures, Teralys Capital, TMFOX, UnityPoint Health Ventures, Versant Ventures, WaterStar Capital LLC, WinnerMax Capital, Xontogeny and Yanyuan Capital Group.

Confirmed Pitching Companies:

ABOzymes Biomedical, Agilik Technologies, Arbutus Medical, ARC Medical Devices, Bold Therapeutics, Claris Healthcare, Connected Things Scientific, CureImmune Therapeutic, Derm-Biome Pharmaceuticals, Fusion Genomics, GenomeMe Lab, HealthTech Connex and NeuroCatch, Heal Mary Technologies, Human in Motion Robotics, Ikomed Technologies, ImmunoFlex, Innotech Medical Industries, Innovakine Therapeutics, Kardium, LifeBooster, LivNao, Medicenna Therapeutics, Microbion Corporation, NervGen Pharma, NZ Technologies, Oak Bay Biosciences, Pramana Pharmaceuticals, Response Biomedical, Sonic Incytes Medical, Variational AI, Vesalius Cardiovascular, XCO Tech and Zucara Therapeutics.

Investor Summit presented by Lumira Ventures is our opportunity to bring together stakeholders in the healthcare innovation ecosystem. Entrepreneurs tell their stories and get feedback and engagement from a wide range of investor stakeholders. Investor participants range from angel investors, venture capital, corporate venture, and foundations. In addition, tech transfer offices, innovation councils, and government ministries and agencies are also present. It is the opportunity for companies to attract attention, solicit support, and secure investment that will aid them in their continued growth trajectory.

The Investor Summit brings together stakeholders in the life sciences ecosystem for an exciting day of innovative company pitches, presentations, and engaging panel discussions. Companies from across the life sciences community will be invited to apply to pitch from the following sectors: Digital Health, Medical Devices, Medical Technology, Diagnostics, and Biotechnology.